NF-kB is a dimeric protein that serves to initiate gene tran scription in higher eukaryotic cells in response to mainly pathogenic stimuli. Its activity is controlled by a third inhibitory subunit, called IkB. When IkB is bound, NF-kB cannot bind to DNA or enter the nucleus but is stored in a latent cytoplasmic form. Upon stimulation of cells IkB is released, which allows the activation of NF-kB. We have analyzed the molecular mechanism underlying the removal of IkB-oc. Distinct extracellular stimuli lead to a phospho rylation of IkB-oc on serines 32 and 36 by a yet unidentified kinase. These modifications do not directly dissociate IkB from NF-kB but render the inhibitor highly susceptible for proteolytic degradation by, presumably, the proteasome. In this paper, we report for the first time that higher molecular mass forms of IkB-oc occur under conditions that lead to a phosphorylation of IkB-oc and activation of NFkB. These IkB-oc variants had discrete molecular masses and were most prominent in cells overexpressing IkB-oc, suggesting the covalent modification of IkB-oc by ubiquitin conjugation. The proteasome inhibitor Cbz-Ile-Glu(0-tBu)-Ala-leucinal (PSI), which stabilizes the phospho form of IkB-oc, only slightly increased the amount of conjugates indicating that the conjugation of IkB-oc with ubiquitin was the rate-limiting step in IkB-oc degradation, and not its phosphorylation or proteolysis. Our data suggest that con jugation of IkB-oc with ubiquitin is an intermediate reaction in the phosphorylation-controlled degradation of IkB-oc and the subsequent activation of NF-kB.
INTRODUCTION
Gene transcription is regulated in two fashions. Either there is a continuous production of mRNA from a gene, or, mRNA pro duction is inducible. Many constitutively transcribed genes encode proteins with a 'house-keeping' function, such as important metabolic and catabolic enzymes. Inducibly tran scribed genes usually encode proteins that are not required until a change in the extracellular environment imposes a special need. For instance, many genes are induced in response to heat shock, viral and bacterial infection or injury. The encoded proteins serve to defend the cell or to alert the immune system. Other important stimuli of gene transcription are internal signals such as hormones or cell-to-cell interactions. Such signals frequently control the expression of genes encoding proteins needed for cell proliferation and differentiation.
Gene transcription is governed by sequence-specific DNA binding proteins, called specific transcription factors or trans activators (reviewed by Baeuerle, 1995) . W hen bound to reg ulatory DNA sequences of a particular gene, these proteins have the potential to recruite basic or general transcription factors to the start site of transcription and allow DNAdependent RNA polymerase II to enter the transcription initiation complex and produce mRNA copies. Inducible tran scription requires that the activity of transactivators is highly controlled. Many distinct strategies have evolved to control these proteins. One is de novo synthesis but this requires yet other transactivators to activate their genes. Some transactiva tors, such as SRF/TCF or CREB, are already bound to DNA but require phosphorylation of their transactivation domain for their activation. The STAT factors are found in the cytoplasm. Only if phosphorylated on tyrosine by cytokine receptor-asso ciated kinases can they dimerize and move into the nucleus. Members of the large family of steroid hormone receptors become activated by binding of a lipophilic ligand. Transcrip tion factors of the NF-KB/Rel family have evolved a quite unique mechanism. They are complexed to inhibitory subunits, called IkB proteins. These prevent their DNA binding and nuclear transport. Only when released in response to various cell stimulations can the active DNA binding proteins enter the nucleus and initiate transcription.
There are currently five members of the NF-KB/Rel family known in higher vertebrates: p65 (RelA), RelB, c-Rel, p50 and p52 (Blank et al., 1992; Grilli et al., 1993; Liou and Baltimore, 1993; Baeuerle and Henkel, 1994; Siebenlist et al., 1995) . All are sequence-specific DNA binding proteins, which recognize with distinguishable specificity so-called kB motifs (consensus: 5'-GGGPuNNPyPyCC-3'). With the exception of p50 and p52, the subunits contain transactivating domains which confer tran scriptional activation. The proteins must homo-or heterodimerize in order to bind with high affinity to DNA. Appar ently, RelB cannot dimerize with p65 or c-Rel, but almost every other dimer combination is possible and has been reported to occur in nuclear extracts prepared from cells. Frequently, the rapidly induced NF-kB complexes contain p65 in a heterodimer with p50 or as homodimers, while c-Rel and RelB are frequent constituents of constitutively nuclear NF-kB in mature B cells.
The inhibitory IkB subunits also constitute a family of proteins: IkB-oc, IkB-(3, iKB-y, Bcl-3, plOO and p l0 5 Gilmore and Morin, 1993) . These differ with respect to their inhibitory specificity and function. While all appear to inhibit the DNA binding of p65-containing complexes, only a few can inhibit DNA binding of p50 dimers. Bcl-3 is unique in that it inhibits p50 dimers but associates with p52 dimers on DNA and provide them with transactivating potential (Bours et al., 1993) . IkB-oc appears responsible for the rapid activation of NF-kB in response to many stimuli. Human IkB -cx is an acidic polypep tide of 318 amino acids (Haskill et al., 1991) . Like the other IkB proteins, it contains a central domain consisting of at least five closely adjacent repeats of a 33 amino acid sequence, called ankyrin repeats. The integrity of this domain is essential for p65 binding and, hence, for the inhibitory activity of IkBoc on DNA binding and nuclear transport (Inoue et al., 1992) . Mutational alteration of any repeat will inactivate the protein.
A C-terminally adjacent acidic sequence is necessary for high affinity p65 binding and for the potential of IkB to dissociate a preformed NF-kB-DNA complex.
One stimulus activating NF-kB in intact cells is the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) (Sen and Baltimore, 1986) . It was therefore attractive to postulate that direct phosphorylation of IkB by PKC disrupts the NF-kB-IkB interaction, releases the inhibitor and activates NF-kB. This was in fact observed in cell-free experiments using purified PKC (Shirakawa and Mizel, 1989; Ghosh and Baltimore, 1990) . Other kinases, such as cAM P-dependent kinase, had the same effect, which would explain the activa tion of NF-kB in response to diverse stimuli by a multi-site phosphorylation of IkB. However, we have observed that an antioxidant, pyrrolidinedithiocarbamate (PDTC), prevented in intact cells phosphorylation of IkB-oc and activation of NF-kB in response to PMA without interfering with PKC activation (Schreck et al., 1992; Traenckner et al., 1994) . PDTC was equally inhibitory with the NF-kB activators TNF-oc and IL-1(3, which do not engage PKC in their signal transduction pathways. This suggested a common signalling step in which PKC played only an indirect role. Other antioxidants or over expression of the enzymes thioredoxin and catalase also prevented NF-kB activation while H2O2 was in some cell types activating itself (Schreck et al., , 1992 Schenk et al., 1994; Schmidt et al., 1995) . These observations led to the hypothesis that reactive oxygen intermediates play a role as common messengers .
A reaction common to diverse NF-KB-activating conditions is the rapid decay of IkB-oc. Although interleukin-1(3 (IL-1), tumor necrosis factor-oc (TNF), PMA and lipopolysaccharide use different receptors they all cause with distinct kinetics a depletion of IkB-oc, which coincides with the appearance of active NF-kB in cells Brown et al., 1993; Cordle et al., 1993; Henkel et al., 1993; Mellits et al., 1993) . IkB-oc has already a high turnover in cells and is continuously replaced within its complex with the more stable NF-kB dimer (Rice and Ernst, 1993) . However, when cells are treated with PMA, a 100-fold increase in the IkB-cx turnover can be measured . This suggested that either a protease was newly activated or that IkB-oc was converted into a better substrate for a constitutive protease. Pharmacological data hinted at the latter possibility. Micromolar concentrations of novel peptide inhibitors of the proteasome prevented NF-kB activation as well as IkB-oc degradation in intact cells (Palombella et al., 1994; Traenckner et al., 1994) . A calpain inhibitor was ineffective. Another effect of the proteasome inhibitors was that they stabilized a newly phosphorylated variant of IkB-oc with a decreased mobility in SDS gels. This showed that a stoichiometric phosphorylation preceeded the inducible degradation of IkB-oc, suggesting that the covalent modification controlled its stability. In contrast to the previous in vitro kinase experiments, this in vivo phosphorylation of IkB-cx was not sufficient to release IkB-oc nor to activate NFkB (Finco et al., 1994; Miyamoto et al., 1994; Traenckner et al., 1994; Alkalay et al., 1995) . In cells treated with the inducer okadaic acid and the proteasome inhibitor CBz-Ile-Glu(O-tBu)-Ala-Leucinal (PSI; Figueiredo-Pereira et al., 1994) , all intra cellular IkB-oc is present in the phospho form but there is no significant NF-kB activation and p65 NF-kB is still tightly bound to the phospho IkB (Traenckner et al., 1994) . This further supported the suggestion that the in vitro experiments with PKC did not faithfully reproduce the situation in intact cells.
Transiently overexpressed IkB-cx is also subject to inducible phosphorylation but is not effectively degraded (Traenckner et al., 1995) . This allowed us and others to investigate truncated and point-mutated variants of human IkB-oc for their phospho rylation and, ultimately, to identify the phosphorylation sites Traenckner et al., 1995) . C-terminally truncated IkB-cc, which had lost its potential PKC site, showed the same phosphatase-sensitive decrease in mobility as the wild-type protein. In contrast, N-terminally truncated IkB-cx was not detectably modified, which identified the N-terminal portion of the protein as its regulatory domain. Any single point mutation of the three hydroxy amino acids in the N-terminal portion of IkB-cx, S32, S36 and Y42, to alanines or phenylala nine, respectively, had no major effect on the inducible upshift. However, a double point mutation in S32 and S36 did not allow any upshift, i.e. phosphorylation. This identified S32 and S36 as the major sites of IkB-cx phosphorylation in response to okadaic acid (OA), PMA and TNF. An S32/36A double mutant as well as single point mutants showed a dominant negative effect in transiently or stably transfected cell lines. The mutants very efficiently prevented kB -dependent reporter gene transac tivation and, in contrast to the endogenous IkB-oc, were no longer degraded in response to cell stimulation. This shows that phosphorlyation on either serine 32 or 36 can lead to a more slowly migrating IkB-oc variant but that phosphorylation on both serines is necessary for an efficient degradation of IkB-cx and activation of NF-kB. The current model of NF-kB activa tion is shown in Fig. 1 . How phosphorylation increases the turnover of IkB-oc remained unanswered. Here, we report that under a condition leading to enhanced IkB-oc phosphorylation and degradation, higher molecular mass variants of IkB-oc become detectable in western blots, indicative of the conjuga tion of IkB-oc with ubiquitin.
MATERIALS AND METHODS

Cell culture and treatments
HeLa cells were grown in Dulbecco's modified Eagle's medium (Zabel et al., 1993) and p65 N F-kB (Schm itz and B aeuerle, 1991) using the calcium phosphate transfection m ethod as described (T raenckner et al., 1995) . pow der (blocking solution). A fter a short w ash in T B ST , the m em brane w as incubated in 1:700 diluted prim ary antibody in blocking solution for 1 h our at room tem perature, follow ed by extensive w ashing with T B ST . B ound antibody w as decorated w ith goat anti-rabbit/horseradish peroxidase conjugate (B io-R ad; diluted 1:3,000 in blocking solution) for 30 m inutes at room tem perature. A fter w ashing for 45 m inutes, the im m une com plexes w ere detected using enhanced chem olum inescence labeling (E C L) w estern blotting reagents (A m ersham ). T he filter w as exposed for several seconds to K odak X A R -5 film s.
Cell extracts and western blotting
Antibody to IkB-cc
A polyclonal antiserum w as raised in rabbits against gel-purified recom binant hum an IkB-oc as described (H enkel et al., 1993; Z abel et al., 1993) . Specific IgG w as affinity-purified by recom binant Ik B -cc coupled to C N B r-activated Sepahrose 4B (Pharm acia). A fter w ashing the affinity colum n at pH 2.0, specific IgG w as eluted by 4 M guadinium hydrochloride and renatured by dialysis against phosphatebuffered saline.
RESULTS
Previous studies have show n that the phosphatase inhibitor OA is a slow inducer o f N F -k B activation (Traenckner et al., 1994) . It takes longer than 20 m inutes before OA induces a signifi cant depletion o f I k B -oc and subsequent activation o f N F -k B in H eLa cells. A fter 60 m inutes a strong activation is seen. Here, w e have investigated w hether endogenous or overex pressed I k B -oc w ould exhibit higher m olecular m ass form s after OA stim ulation o f H eL a cells. H igher m olecular mass form s of discrete m olecular m asses in SDS gels are indicative o f the conjugation o f a protein with ubiquitin (review ed by Finley and C hau, 1991; Jentsch, 1992) . This was tested by staining w estern blots o f total H eL a cell extracts w ith an affinity-purified polyclonal anti-lK B -a IgG.
As seen in a long exposure o f a fluorogram from a w estern blot, virtually no higher m olecular mass form s o f I k B -cx w ere detected in control cells (Fig. 2, lane 6) , or in cells transiently transfected with 5 |ig expression plasm ids for IK B -a and p65 (lane 1). Faster-m igrating degradation products were also not present in significant am ounts. A fter a 20-m inute treatm ent of H eLa cells with OA, a slightly increased degradation o f I K B -a was observed, but no higher m olecular mass form s accum ulated (lanes 2 and 7). Sixty m inutes after OA stim ulation, the specific antibody detected m ore slowly m igrating variants o f I kB -oc with discrete m olecular masses (Fig. 2, lanes 3 and 8) . Next, we tested the effect o f the proteasom e inhibitor PSI. U biquitinated form s o f proteins are thought to be degraded by the proteasom e (review ed by H ochstrasser, 1992; H ershko and Ciechanover, 1992) . H ence (partial) inhibition o f the m ulticatalytic enzym e should increase the steady state level o f ubiquitin conjugates. As show n in Fig. 2 , total cell extracts from 20 m inute O A -treated H eL a cells preincubated w ith 60 pM PSI indeed contained significantly m ore conjugates (lane 4) than control cells (lane 2). T his was, how ever, only evident w hen I k B -oc w as overexpressed (com pare to lanes 7 and 9). N o increased am ounts o f conjugates w ere detected after a 60 m inute OA treatm ent in the presence of PSI (com pare lanes 3 and 5), suggesting that it w as not the proteasom e activity that w as rate-lim iting but the conjugation reaction. A pparently, the degradation o f conjugated I kB -oc by the proteasom e is also highly efficient since a proteasom e inhibitor does not lead to accum ulation o f conjugated I kB -oc. C onsequently, the second reaction, the conjugation w ith ubiquitin, is the rate-lim iting step in IkB -oc degradation. T he bracket sym bolizes the highly transient nature o f u biquitin-conjugated Ik B -oc, as is evident from the present study.
DISCUSSION
In this study, w e provide evidence that conditions prom oting IkB -oc phosphorylation and degradation lead to an enhanced conjugation o f IkB -oc with ubiquitin. Firstly, higher m olecular m ass form s o f Ik B-oi only appeared under those conditions that w ere associated with increased IkB-oc phosphorylation and N F -kB activation (com pare to Fig. 1 in T raenckner et al., 1995) . No such form s were seen under non-inducing or suboptim al conditions. Secondly, the appearance of higher m olecular m ass form s o f IkB-oc correlated with the appearance o f IkB -cc degradation products o f reduced m olecular mass. Thirdly, the m olecular mass increm ents o f IkB -oc are consis tent w ith the addition o f various num bers o f ubiquitin units. Fourthly, inhibition o f proteasom e activity in intact cells by the peptide inhibitor PSI caused an increase in the am ount o f IkBoc conjugates under suboptim al stim ulatory conditions. Finally, the am ount o f higher m olecular mass form s did increase with the am ount o f cellular IkB-oc. In conclusion, it is very likely that w e have observed for the first tim e the conjugation o f IkBoc w ith ubiquitin in the course o f its phosphorylation-induced degradation. M ore direct biochem ical evidence may com e from probing IkB -oc im m unoprecipitates with ubiquitinspecific antibodies and from cell-free conjugation reactions. The observation o f conjugates only in highly overexposed fluorogram s show s that they are very transient and occur at low concentration. This is consistent with the idea that ubiquitin conjugates o f proteins represent short-lived interm ediates in a general protein degradation pathw ay of the cell. U biquitin-conjugated proteins are thought to be degraded by the proteasom e (review ed by H ochstrasser, 1992). W hy then did PSI not lead to the accum ulation o f increased am ounts of IkB -oc conjugates (com pare lanes 3 and 5 in Fig. 2) ? W e have observed earlier that overexpressed 1kB-cc can still be effi ciently phosphorylated but not degraded in H eL a cells (Traenckner et al., 1995) . T his show s that the protease system but not the kinase is easily overcharged by overexpressed IkBoc. The protease system com prises at least tw o reactions: the conjugation o f phosphorylated IkB-oc w ith ubiquitin and the subsequent degradation o f the conjugate by the proteasom e. Because inhibition o f the proteasom e by PSI did not enhance the accum ulation o f IkB -oc conjugates, m ost likely it was not the protease that was rate-lim iting but the enzym e(s) conju gating IkB -oc with ubiquitin. O nly under suboptim al con ditions, in which the conjugating enzym e finds low am ounts of phosphate-tagged Ik B -cc substrate, should PSI be able to stabilize IkB -oc conjugates. This w as in fact observed (Fig. 2 , com pare lanes 2 and 4). Fig. 3 show s a m odel sum m arizing these considerations.
T here are an increasing num ber o f exam ples in w hich ubiquitin plays a crucial role in the degradation o f im portant cellular regulatory proteins (review ed by H ochstrasser, 1992; H ershko and Ciechanover, 1992). Cyclins, p53, c-Jun and G C N 4 all have been reported to be conjugated to ubiquitin. T he degradation o f Ik B -c c appears to use a sim ilar pathway. T here is now evidence to suggest that the enzym e(s) conju gating IkB -oc w ith ubiquitin has a higher affinity for IkB -oc w hich is phosphorylated on both serines 32 and 36. It is inter esting to note that lysine residues are contained in sequence positions 38 and 47 o f hum an IkB -oc, which is very close to the tw o phosphoserine residues. Lysine is the acceptor am ino acid for ubiquitin. Future studies will identify the conjugating enzym e(s) and determ ine the site(s) o f ubiquitin conjugation in IkB -oc. An interesting question is how specific the enzym e is that conjugates IkB -oc w ith ubiquitin. It could constitute a potential target for novel anti-inflam m atory drugs, preventing the activation o f N F -k B during, for instance, septic shock or allograft rejection.
